Showing results (151-160 of 250) with videos related to
Sort By:
Pageof 25
Clinical and Translational Radiation Oncology|March 11, 2026
Radiotherapy patterns and factors associated with pneumonitis in PACIFIC-R, a real-world study of patients with unresectable stage III non-small-cell lung cancer treated with durvalumab after chemoradiotherapyAndrea R Filippi, Jair Bar, Daniel C Christoph, et al.American Journal of Industrial Medicine|January 9, 2024
Prevalent occupational exposures and risk of lung cancer among women: Results from the application of the Canadian Job-Exposure Matrix (CANJEM) to a combined set of ten case-control studiesMengting Xu, Vikki Ho, Jérôme Lavoué, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 28, 2022
Treatment Characteristics and Real-World Progression-Free Survival in Patients With Unresectable Stage III NSCLC Who Received Durvalumab After Chemoradiotherapy: Findings From the PACIFIC-R StudyNicolas Girard, Jair Bar, Pilar Garrido, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 26, 2025
Lung Cancer Screening Program Quality Indicators-Review and Recommendations: An International Association for the Study of Lung Cancer Delphi Process StudyMartin C Tammemägi, Andrea Borondy-Kitts, John K Field, et al.Cancer Prevention Research (Philadelphia, Pa.)|January 21, 2014
The UK Lung Screen (UKLS): demographic profile of first 88,897 approaches provides recommendations for population screeningFiona E McRonald, Ghasem Yadegarfar, David R Baldwin, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 3, 2019
Investigation of Leukocyte Telomere Length and Genetic Variants in Chromosome 5p15.33 as Prognostic Markers in Lung CancerLinda Kachuri, Jens Helby, Stig Egil Bojesen, et al.Human Molecular Genetics|October 21, 2015
Identification of shared and unique susceptibility pathways among cancers of the lung, breast, and prostate from genome-wide association studies and tissue-specific protein interactionsDavid C Qian, Jinyoung Byun, Younghun Han, et al.European Journal of Cancer (Oxford, England : 1990)|March 1, 2025
Action plan for an international imaging framework for implementation of global low-dose CT screening for lung cancerHarriet L Lancaster, Anna N H Walstra, Kyle Myers, et al.JCO Clinical Cancer Informatics|February 7, 2020
The International Association for the Study of Lung Cancer Early Lung Imaging ConfederationJames L Mulshine, Ricardo S Avila, Ed Conley, et al.Health Technology Assessment (Winchester, England)|May 26, 2016
The UK Lung Cancer Screening Trial: a pilot randomised controlled trial of low-dose computed tomography screening for the early detection of lung cancerJohn K Field, Stephen W Duffy, David R Baldwin, et al.Pageof 25